Tirzepatide

Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual agonist for glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. This unique structure makes it a valuable tool for researchers studying metabolic regulation and endocrine functions in controlled laboratory environments. Scientists utilize Tirzepatide in preclinical models to explore its effects on energy balance, glucose metabolism, and related pathways, offering insights into the integrated actions of incretin hormones. Its dual receptor activity is particularly useful for comparative studies against single-receptor agonists, providing a deeper understanding of complex metabolic mechanisms. Each batch is third-party verified for >99% purity, ensuring precision and reliability in experimental results.

All references to metabolic effects, including those related to energy balance, reflect observations from controlled laboratory research only. This product is intended solely for research purposes and is not for human or animal consumption, nor is it approved for diagnostic, therapeutic, or clinical applications. Restricted to use by qualified research professionals.